| dc.contributor.author | OH Zachariah, MA Lizzy, K Rose, MM Angela | |
| dc.date.accessioned | 2022-01-26T12:10:16Z | |
| dc.date.available | 2022-01-26T12:10:16Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/4660 | |
| dc.description | https://doi.org/10.1186/s12879-021-05788-3
https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-021-05788-3.pdf | en_US |
| dc.description.abstract | Diarrhoea is a common cause of mortality and morbidity in children under five years old. In Kenya, it has a 21% case fatality with Enteropathogenic E. coli, Campylobacter jejuni, Shigella spp. and Salmonella spp. accounting for 50–60% of the cases. Sulphonamides, tetracycline, ampicillin and trimethoprim/sulfamethoxazole are typically used in the treatment of diarrhoeal diseases but have become ineffective in the face of emerging antimicrobial resistance. The objective of this study was to evaluate the prevalence and antimicrobial susceptibility of Campylobacter jejuni and Shigella species in children under five years of age presenting with diarrhoea at Kapsabet County Referral Hospital in Kenya. | en_US |
| dc.publisher | Springer | en_US |
| dc.title | Multiple drug resistance of Campylobacter jejuni and Shigella isolated from diarrhoeic children at Kapsabet County referral hospital, Kenya | en_US |
| dc.type | Article | en_US |
